Why did Enlitic (ASX:ENL) execute a new capital raising agreement?

Enlitic (ASX:ENL) executed the agreement to fund its ongoing operations through to cashflow break-even. The company secured binding commitments to raise approximately $15 million before costs through a conditional placement.

What are the primary financial details of the Enlitic (ASX:ENL) equity capital raising?

Enlitic (ASX:ENL) is raising approximately $15 million through a conditional placement, alongside a security purchase plan targeting up to approximately $1 million. Following the announcement, the company's share price rose 20% to $0.006.

What does the capital restructure mean for the Enlitic (ASX:ENL) share structure?

The transaction details for Enlitic (ASX:ENL) include a proposed 10:1 share consolidation and the conversion of existing convertible notes. The company stated that these moves are intended to deliver a simplified capital structure and extinguish outstanding debt.

How is Enlitic (ASX:ENL) predicting its financial runway will change?

Enlitic (ASX:ENL) forecasts that the transaction proceeds will provide the business with an operational runway of over 12 months. The company expects its pro forma cash to stand at approximately A$18 million upon completion of the placement.

Image for illustrative purposes only. Not a real photo.

Enlitic secures commitments for $15M placement

Q: How is Enlitic (ASX:ENL) deploying these funds into the healthcare market?

Enlitic (ASX:ENL) plans to deploy the capital to support the commercial scale-up of its software products that use artificial intelligence to manage medical imaging data. The company stated that the proceeds will primarily fund the roll-out of its software-as-a-service enterprise offering.

Written by Mahathir BayenaPublished Jul 3, 2026, 5:11 AM

Enlitic secured binding commitments for a conditional placement to raise approximately $15 million before costs.
The company's stock rose 20% to $0.006 following the resumption of trading on the Australian Securities Exchange.
Proceeds will fund ongoing operations through to cashflow break-even and expand enterprise sales for its healthcare software.

Enlitic (ASX:ENL) executed an agreement to raise approximately $15 million through a conditional placement of new fully paid CHESS Depositary Interests to fund operations.

The capital raising follows a two-day trading halt requested by the company on July 1 pending the outcome of the equity offer.

"This capital raising represents a pivotal moment for Enlitic," said Enlitic CEO Michael Sistenich.

The transaction details also include a proposed 10:1 share consolidation and an additional security purchase plan targeting up to approximately $1 million.

The company stated that the transaction is expected to provide an operational runway of over 12 months, and following the announcement the Enlitic share price was up at $0.006.

The funding will primarily support the commercial scale-up of the company's software products that use artificial intelligence to manage medical imaging data.

This capital restructure follows previous commercial progress this year, which included data migration agreements with hospital groups such as Parkland Health and Penn Medicine.

Enlitic secures commitments for $15M placement

Frequently asked questions

Assets related to this article